- Home
- AARD vs MLGO Comparison
AARD vs MLGO Comparison
Compare AARD & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- MLGO
- Stock Information
- Founded
- AARD 2017
- MLGO 2018
- Country
- AARD United States
- MLGO China
- Employees
- AARD N/A
- MLGO N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- MLGO EDP Services
- Sector
- AARD Health Care
- MLGO Technology
- Exchange
- AARD Nasdaq
- MLGO Nasdaq
- Market Cap
- AARD 154.9M
- MLGO 139.5M
- IPO Year
- AARD 2025
- MLGO N/A
- Fundamental
- Price
- AARD $6.93
- MLGO $11.86
- Analyst Decision
- AARD Strong Buy
- MLGO
- Analyst Count
- AARD 4
- MLGO 0
- Target Price
- AARD $31.50
- MLGO N/A
- AVG Volume (30 Days)
- AARD 129.3K
- MLGO 36.8M
- Earning Date
- AARD 01-01-0001
- MLGO 04-29-2025
- Dividend Yield
- AARD N/A
- MLGO N/A
- EPS Growth
- AARD N/A
- MLGO N/A
- EPS
- AARD N/A
- MLGO N/A
- Revenue
- AARD N/A
- MLGO $83,504,125.00
- Revenue This Year
- AARD N/A
- MLGO N/A
- Revenue Next Year
- AARD N/A
- MLGO N/A
- P/E Ratio
- AARD N/A
- MLGO N/A
- Revenue Growth
- AARD N/A
- MLGO 643.57
- 52 Week Low
- AARD $4.88
- MLGO $1.11
- 52 Week High
- AARD $19.58
- MLGO $509.60
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- MLGO 49.65
- Support Level
- AARD N/A
- MLGO $6.42
- Resistance Level
- AARD N/A
- MLGO $23.40
- Average True Range (ATR)
- AARD 0.00
- MLGO 4.95
- MACD
- AARD 0.00
- MLGO -1.46
- Stochastic Oscillator
- AARD 0.00
- MLGO 20.94
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments Central processing algorithm services & Intelligent chips and services. The majority is from the Central processing algorithm services. which refer to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.